Earnings calendar/IMMX
Immix Biopharma, Inc. (IMMX)
Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.
Pre-earnings
Consensus targets for the next print, plus how the business has been running.
Next report
Nov 6, 2026
Consensus estimate row
EPS target
$-0.18
Street estimate
Revenue target
—
Street estimate
Trailing EPS (avg 4Q)
$-0.20
Beat rate last 4: 25%
Latest EPS YoY
+18.2%
vs 2025-08-08
Latest revenue YoY
—
How results look so far
Trailing revenue (avg 4Q)
—
Printed quarters
EPS beat rate (4Q)
25%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Aug 7, 2026
EPS miss
EPS actual / est
$-0.18 / $-0.17
-5.9%
Revenue actual / est
— / —
—
Result
Below target
Based on EPS vs consensus
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 11/6/2026upcoming | $-0.18 | Pending | — | — | Pending | — |
| 8/7/2026 | $-0.17 | $-0.18 | -5.9% | — | Pending | — |
| 5/14/2026upcoming | $-0.14 | Pending | — | — | Pending | — |
| 5/7/2026 | $-0.21 | $-0.18 | +14.3% | — | Pending | — |
| 3/25/2026 | $-0.21 | $-0.27 | -28.6% | — | Pending | — |
| 3/23/2026 | $-0.14 | $-0.17 | -17.2% | — | Pending | — |
| 11/7/2025 | $-0.19 | $-0.24 | -26.3% | — | Pending | — |
| 8/8/2025 | $-0.21 | $-0.22 | -4.8% | — | Pending | — |
| 5/8/2025 | $-0.23 | $-0.15 | +34.8% | — | Pending | — |
| 3/24/2025 | $-0.25 | $-0.16 | +36.0% | — | $96,290 | — |
| 11/12/2024 | $-0.16 | $-0.24 | -50.0% | — | Pending | — |
| 8/12/2024 | $-0.21 | $-0.15 | +28.6% | — | Pending | — |
| 5/9/2024 | $-0.23 | $-0.22 | +4.3% | — | Pending | — |
| 3/29/2024 | $-0.23 | $-0.24 | -4.3% | — | $4,784 | — |
| 11/9/2023 | $-0.23 | $-0.23 | 0.0% | — | Pending | — |
| 8/11/2023 | $-0.17 | $-0.24 | -41.2% | — | Pending | — |
| 5/12/2023 | $-0.14 | $-0.18 | -28.6% | — | Pending | — |
| 3/27/2023 | $-0.22 | $-0.27 | -22.7% | — | $-89.5M | — |
| 11/9/2022 | — | $-0.11 | — | — | Pending | — |
| 8/12/2022 | — | $-0.11 | — | — | Pending | — |
| 5/13/2022 | — | $-0.10 | — | — | Pending | — |
| 3/28/2022 | — | $-3.00 | — | — | Pending | — |
| 9/30/2021 | — | $-0.06 | — | — | Pending | — |
| 6/30/2021 | — | $-0.02 | — | — | Pending | — |
| 3/31/2021 | — | $-0.12 | — | — | Pending | — |
| 12/31/2020 | — | $-0.10 | — | — | Pending | — |
| 9/30/2020 | — | $-0.02 | — | — | Pending | — |
| 6/30/2020 | — | $-0.04 | — | — | Pending | — |
| 3/31/2020 | — | $-0.04 | — | — | Pending | — |
Need IMMX data in your own agent or pipeline?
The earnings data on this page — report dates, consensus EPS/revenue estimates, actuals and surprise history — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.